COMP <GO>
DFTX vs PM // RSI-14 & 200D SMA MOMENTUM
Definium Therapeutics Inc. (NASDAQ) VS. Philip Morris International Inc (NYSE) • 15-METRIC TALLY: DFTX 2
— PM 10
▲ RSI-14 & 200D SMA MOMENTUM LEADER: PM
LAST: $36.33 (-4.29%) • MKT CAP: $5.10B
rsi-technicals
55.4
LAST: $208.79 (+0.14%) • MKT CAP: $324.98B
rsi-technicals
63.9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DFTX VS. PM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | DFTX | PM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 67.10% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -32.20% | 45.30% | -77.50 | PM | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 21.7x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -3.84% | 3.28% | -7.12 | PM | /fcf-yield <GO> |
| Operating Margin | -11.60% | 36.60% | -48.20 | PM | /operating-margins <GO> |
| Net Profit Margin | -12.90% | 27.90% | -40.80 | PM | /net-margins <GO> |
| Revenue Growth (YoY) | 5.50% | 7.30% | -1.80 | PM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.65% | -2.65 | PM | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 26.00 | 4.52 | +21.48 | DFTX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 8/9 | -3.00 | PM | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 55.4 | 63.9 | -8.50 | PM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.08 | 0.93 | +0.15 | DFTX | /macro-sensitivity <GO> |
| Forward P/E Multiple | 33.0x | 26.6x | +6.40 | PM | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.10B | $324.98B | -$319.88B | PM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | DFTX REV | PM REV | DFTX GROSS % | PM GROSS % | DFTX FCF | PM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $40.65B | — | 67.1% | -$131.6M | $10.66B |
| FY 2024 | $0 | $37.88B | — | 64.8% | -$79.1M | $10.77B |
| FY 2023 | $0 | $35.17B | — | — | -$64.4M | $7.62B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
DFTX // BETA 1.08
PM // BETA 0.93